baber/WOPTO huggingface dataset:
Patent NZ-550489-A (NZ)
Title: Mattress with surface channels in inclined portion to dissipate body heat away, typically for babies
Inventor: OWEN PHILIP
IPC: A47C27/00
Filed: 2005-03-14
Abstract: A mattress (2), comprising: a resilient body having at least one upper surface portion for supporting a person (such as a small child or baby); and a plurality of surface channels (30) disposed in the or each upper surface portion and extending parallel thereto. The upper surface portions (for example three, including separate surface portions for supporting the head and the body) are inclined relative to the horizontal (or preferably, suitably anatomically sloped). The surface channels (30) have a component of direction in the direction of rising slope. In consequence, warm air that has been heated by contact with the person's body, in order to rise, passes along the surface channel (30) and out to the surrounding atmosphere. Thus, heat is dissipated away from the person's body and helps to prevent overheating.
Patent NZ-553069-A (NZ)
Title: Integrated process for synthesizing alcohols, ethers, and olefins from alkanes using a multi-zone reactor
Inventor: GROSSO PHILIP
IPC: C07C41/01
Filed: 2005-02-02
Abstract: A method of converting alkanes to corresponding alcohols, ethers, olefins, or products comprising a higher number of carbon atoms is disclosed, which comprises the steps of: a. providing a substantially imperforate chamber having first and second ends and comprising a first reactant receiving zone located at the first end thereof, a second reactant receiving zone located at the second end thereof, and a centrally disposed reaction zone located between the first reactant receiving zone and the second reactant receiving zone; b. providing a quantity of metal halide; c. positioning the quantity of metal halide in the first reactant receiving zone of the chamber; d. providing a quantity of metal oxide; e. positioning the quantity of metal oxide in the second reactant receiving zone of the chamber; f.providing an oxidizing gas; g. reacting the oxidizing gas with the metal halide and thereby producing gaseous halide and metal oxide; h. providing a quantity of alkane; i. directing the alkane into the reaction zone of the chamber; j. reacting the alkane with the gaseous halide produced in step g. in the reaction zone located centrally and thereby producing an alkyl halide; k. reacting the alkyl halide produced in step j. with the metal oxide and thereby producing corresponding alcohols, ethers, olefins, or products comprising a higher number of carbon atoms and metal halide; and l. recovering the corresponding alcohols, olefins, or products comprising a higher number of atoms produced in step k. from the chamber.
Patent NZ-553687-A (NZ)
Title: RNA sequence-specific mediators of RNA interference
Inventor: TUSCHL THOMAS
IPC: C12N/
Filed: 2001-03-30
Abstract: Disclosed is an isolated double-stranded RNA of from about 21 nucleotides to 23 nucleotides that is perfectly complementary to an mRNA and mediates RNA interference by directing cleavage of the mRNA to which it is perfectly complementary, wherein cleavage of the mRNA is directed within the region that is perfectly complementary with the isolated RNA, and wherein the mRNA is mammalian cellular mRNA or viral mRNA. Also disclosed are analogs, methods of production, methods of use and pharmaceutical compositions encompassing the disclosed isolated double-stranded RNA.
Patent NZ-556175-A (NZ)
Title: System and method of operating a customer loyalty program
Inventor: WILLISON JASON JAMES
IPC: G06Q30/00
Filed: 2005-12-02
Abstract: A system for operating a customer loyalty program comprises means for allocating a unique identifier to a customer participating in the customer loyalty program; means for establishing a customer loyalty account linked to the unique identifier for accumulating customer loyalty points earned by the participating customer; means for transferring or establishing a financial instrument for the participating customer to/with at least one participating institution of a first type; means for awarding customer loyalty points to the participating customer based on the value and/or quantity of purchases performed by the customer with one or more participating institutions of a second type using their unique identifier; means for providing a discounted rate of interest applied to the financial instrument based on the customer achieving a pre-determined loyalty points threshold within a periodic specified time interval; and means for monitoring the customer loyalty account to ensure that the total of the loyalty points accrued during each subsequent one of the periodic specified time intervals exceeds the predetermined threshold whereby the customer may continue to enjoy the benefit of the discounted rate of interest applied to the financial instrument.
Patent NZ-556258-A (NZ)
Title: Message centre call handling
Inventor: SMITH BRYAN LESLIE
IPC: G06Q50/00
Filed: 2007-07-02
Abstract: An SMS or MMS message call centre for responding to digitally recorded messages received from callers, and a method for handling SMS or MMS calls to such, is disclosed. The call centre comprises: a message recording database, a message parser, a message classifier, a message response producer, a message relayer, and a response message generator. The message recording database records at least a called number, a calling number, a message, and a message status. The message parser separates the messages on the basis of at least the called number and the presence or absence of at least one known text string in the message, and the message classifier classifies messages for attention by an operator on the basis of parsed results and any previous calls from the same called number. The message response producer produces response messages to a caller in response to any action or lack of action by an operator, and the message relayer relays messages to the operator for reply to the message. The response message generator generates a response to the caller on multiple events in the processing of the message.
Patent NZ-560377-A (NZ)
Title: System and method for evaluating initiatives adapted to deliver value to a customer
Inventor: WELLER ANDREW
IPC: G06Q10/00
Filed: 2006-02-03
Abstract: A value data system including a database component and a user interface component is provided. The database component includes initiative data representing at least one initiative, adapted to deliver value to a customer of an organisation; risk data associated with the initiative data, representing risks corresponding to the at least one initiative; task data associated with the initiative data, representing tasks to be performed to perform the initiative, including risk mitigation tasks for mitigating the risks; and value data associated with the initiative data, representing values delivered to the customer as a result of performing the at least one initiative. The user interface component is used for defining the initiative data, the risk data, the task data, the value data and the associations between them; and defining value data representing values delivered to the customer as a result of performing the initiative.
Patent NZ-567710-A (NZ)
Title: Building board with two outer layers and a centre layer with multiple slanted cavities
Inventor: BERGER JOHANN
IPC: B32B3/12
Filed: 2006-04-06
Abstract: A building board with a multi-layer structure, comprising two cover layers, and at least one core layer with multiple cavities is disclosed. The two cover layers (3, 4) are spatially separated from each other and placed parallel to each other and the at least one core layer (5) of wood with multiple cavities (6, 6') is placed between them and joined to them. The two cover layers (3, 4) each comprise a layer, plate or foil material selected from the group consisting of: wood, wooden material, laminated wood, plywood, wood chip material or resinbound wood, metals, textile and fiber materials, cardboard, papers, plastics, fiber-reinforced plastics, mineral-based construction materials, rock, artificial stone as well as composite materials made of two or more of the materials just named. The at least one core layer (5) comprises at least one single-layer slanted-fiber core layer (5), joined to the cover layers (3, 4). The single-layer slanted-fiber core layer (5) is formed from a wood having a unitary fiber structure. The cavities (6, 6') have a slanted angle to the cover layers (3, 4) and the fibers of the slanted-fiber core layer (5) from a positive angle of +25° to +80°, and/or a negative angle of -25° to -80°, to the area of the two cover layers (3, 4). The slanted-fiber core layer (5) has a multiplicity of the positively-slanted and/or negatively-slanted slant cavities (6, 6') that fully run through the slanted fiber core layer (5) parallel to the particular fiber direction.
Patent NZ-568910-A (NZ)
Title: Indole sulfonamide modulators of progesterone receptors
Inventor: DODGE JEFFREY ALAN
IPC: A61K31/404
Filed: 2007-01-17
Abstract: Disclosed is an indole sulphonamide compound of formula (I) wherein the substituents are as described in the disclosure. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and a method for preparing a compound of formula (I). Further disclosed is the use of a compound of formula (I) in the manufacture of a medicament for treating or preventing leiomyomas and endometriosis in a mammal.
Patent NZ-570134-A (NZ)
Title: Methods and compositions for the treatment of gastrointestinal disorders
Inventor: CURRIE MARK G
IPC: C07K7/06
Filed: 2004-01-28
Abstract: Provided is a pharmaceutical composition comprising:(a) a polypeptide selected from amino acid sequence (i) Cys Cys Glu Phe Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr; (ii) Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr; and (iii) Cys Cys Glu Trp Cys Cys Asn Pro Ala Cys Thr Gly Cys Tyr; (b) an agent selected from: (i) a proton pump inhibitor; (ii) an H2 receptor agonist; (iii) an opioid receptor antagonist; and (iv) an opioid receptor agonist; and (c) a pharmaceutically acceptable carrier. Further provided are methods of producing the polypeptides and pharmaceutical compositions. (62) Divided Out of 541595
Patent NZ-575509-A (NZ)
Title: A lice comb
Inventor: MAOR MOSHE
IPC: A01K13/00
Filed: 2007-08-23
Abstract: A lice comb (10) is disclosed. The comb has parallel teeth (12) with upper (16) and lower surfaces (18). Each pair of adjacent teeth (12) includes a first set of ribs (22) on a side surface (24) of one tooth and a second set of ribs (26) on a side surface (28) of the adjacent tooth. The first set of ribs (22) are provided along the length of the tooth. The second set of ribs (26) are interspersed between the first set of ribs (22) and offset from the first set of ribs in a direction toward the lower surface (18) of the teeth (12). In use, hair moves downwardly between the pair of teeth (12), and it passes through the gaps (32) between the first set of ribs (22) and is deflected in a direction parallel to the teeth (12) by the second set of ribs (26).
Patent NZ-580698-A (NZ)
Title: Calculating credit worthiness using transactional data
Inventor: HALSTED MARC DOUGLAS
IPC: G06Q40/02
Filed: 2008-04-24
Abstract: A method of determining credit worthiness of a customer and a system for loan processing are disclosed. The system comprises a computer with the computer comprising a memory and a processor. The processor executes computer-executable instructions in the memory for receiving transactional data corresponding to transactions at an institution associated with a customer; generating a categorized transactional index based on the transactional data; generating a cash flow statement based on the categorized transactional data; generating a net worth statement with the customer has an account outside of the institution and amount of assets held in the account is calculated using the transactional data; weighting the generated cash flow statement and the net worth statement; calculating a share of wallet for the customer indicating a percentage of a customer's financial requirement filled by the institution; weighting the share of wallet along with the generated cash flow statement and net worth statement; determining credit worthiness based on the weighted share of wallet, cash flow statement, net worth statement, and categorized transactional index where the net worth statement includes the account outside of the institution; and originating a loan based on the determined credit worthiness of the customer. A system and a method for determining credit worthiness of a customer are disclosed. The system comprises a computer with the computer comprising a memory and a processor. The processor executes computer-executable instructions in the memory for receiving transactional data corresponding to transactions associated with a customer; categorizing the transactional data into at least luxury transactions and necessity transactions; calculating, using the computer, a luxury index based on a ratio of a dollar amount of the luxury transactions to a dollar amount of the necessity transactions, where the luxury index is adjusted based on a luxury ratio momentum trend index; determining, using the computer, credit worthiness of the customer based on the calculated luxury index; and originating a loan based on the determined credit worthiness of the customer.
Patent NZ-586508-A (NZ)
Title: Antibacterial condensed thiazoles
Inventor: HAYDON DAVID JOHN
IPC: A61K31/428
Filed: 2008-12-12
Abstract: The disclosure relates to a benzothiazol derivative compounds of formula (I) or a salt or N-oxide thereof, wherein the variables are as defined in the specification. These compounds have antibacterial activity and are suitable for the treatment of a bacterial infection.
Patent NZ-589522-A (NZ)
Title: Current sensor assembly for three-phase cable with three Faraday optical sensor elements
Inventor: SORENSEN FREDDY
IPC: G01R15/24
Filed: 2009-07-21
Abstract: Disclosed is a system for measuring the currents in a three-phase cable (14). The three-phase cable (14) is comprised of individual circular sector-shaped phase conductors (16a, 16b, 16c) insulated in relation to one another and being encapsulated inside an insulator (18). The three-phase cable (14) defines a longitudinal dimension along said three-phase cable (14) and a radial dimension perpendicular to the longitudinal dimension. The system (14) is comprised of a Faraday optical current sensor arrangement (10) comprising three Faraday optical current sensors (12a, 12b, 12c) for measuring three magnetic field values and a processing unit. The Faraday optical current sensors (12a, 12b, 12c) are fixedly arranged at respective measurement positions outside the three-phase cable (14) and adjacent an outer surface of said three-phase cable (14). The processing unit is configured to calculate a current value from a magnetic field value and calculate the current in each of the circular sector-shaped phase conductors (16a, 16b, 16c) by using three magnetic field values.
Patent NZ-590184-A (NZ)
Title: Solid forms of (2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol and methods of their use
Inventor: DE PAUL SUSAN MARGARET
IPC: A61K31/70
Filed: 2009-07-15
Abstract: Disclosed herein are compositions and pharmaceutical dosage forms (preferably a tablet, capsule or caplet) comprising an active pharmaceutical ingredient and a pharmaceutically acceptable excipient, wherein the active pharmaceutical ingredient is crystalline anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol. Also disclosed is the use of crystalline anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol in the manufacture of a medicament for treatment or management of atherosclerosis, cardiovascular disease, diabetes (Type 1 or 2), hyperglycemia, hypertension, lipid disorders, obesity, or Syndrome X.
Patent NZ-591701-A (NZ)
Title: Use of tnf inhibitor for treatment of erosive polyarthritis
Inventor: HOFFMAN REBECCA S
IPC: A61K39/395
Filed: 2006-05-16
Abstract: Provided is the use of an isolated human anti-TNFa antibody, or antigen binding portion thereof, in the manufacture of a medicament for treating erosive polyarthritis in a human subject having psoriatic arthritis, wherein the human anti-TNFa antibody, or an antigen-binding portion thereof, dissociates from human TNFa with a Kd of 1 x 10-8 M or less and a Koff rate constant of 1 x 10-3 s-1 or less, both determined by surface plasmon resonance, and neutralizes human TNFa cytotoxicity in a standard in vitro L929 assay with an IC50 of 1 x 10-7 M or less. Further provided are specific sequences for suitable 6 CDRs in such an antibody.
Patent NZ-596283-A (NZ)
Title: Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
Inventor: CHEW LAWRENCE C
IPC: C12N15/65
Filed: 2010-05-10
Abstract: 596283 Provided is a method for producing a recombinant polypeptide of interest comprising: a) obtaining a population of cells auxotrophic for a first metabolite and a second metabolite, wherein said second metabolite is a natural amino acid; b) introducing into cells of said population a first nucleic acid construct comprising an auxotrophic selection marker, wherein said auxotrophic selection marker comprises a first nucleic acid sequence encoding at least one polypeptide active in the biosynthesis of said first metabolite, and wherein expression of said auxotrophic selection marker restores prototrophy for the first metabolite; c) introducing into cells of said population a: (i) a second nucleic acid sequence encoding said recombinant polypeptide of interest; and (ii) a promoter operably attached to said second nucleic acid sequence so as to direct expression of the second nucleic acid sequence; d) subjecting said population of cells to a first medium lacking said first metabolite under conditions such that transformed cells having restored prototrophy for the first metabolite are obtained; and e) subjecting said transformed cells to a second medium comprising a non-natural amino acid correlating to said second metabolite under conditions such that said second nucleic acid sequence is expressed to produce said recombinant polypeptide of interest having said non-natural amino acid incorporated therein; wherein said first medium and said second medium are the same or different; and wherein said second nucleic acid sequence is provided on said first nucleic acid construct or a second nucleic acid construct separate to said first nucleic acid construct.
Patent NZ-597640-A (NZ)
Title: A wind turbine wherein the parameter values representing oscillation of the drive train is used to damp oscillations
Inventor: WOHLLEB MATTHIAS
IPC: F03D11/02
Filed: 2012-01-17
Abstract: Disclosed is a wind turbine (13) comprising a drive train (22) connecting a rotor (14) to a generator (45), a braking device (43) and a control device. During operation, the control device makes use of parameter values representing an oscillation of the drive train (22) to derive control instructions. These control instructions are used to exert damping forces on the drive train (22) by means of the braking device (43). The damping forces counteract the oscillation of the drive train (22) in a controlled manner. The control instructions are generated on the basis of precontrol signals that are derived from the parameter values.
Patent NZ-601883-A (NZ)
Title: Systems and methods for energy management between a utility provider and a consumer
Inventor: ACOSTA-CAZAUBON JESUS
IPC: H04W4/24
Filed: 2012-08-16
Abstract: 601883 A method of providing access to a consumer utility account (209) for energy management between a utility provider (208) and a consumer (207) is disclosed. A unique identifier of a mobile device is registered with the utility provider with the unique identifier is associated with the consumer. A readable code is transmitted to the utility provider with the mobile device with the readable code is associated with at least one utility meter having a readable code. The readable code is associated with at least one utility meter. An indication associated with verifying that the mobile device is associated with the readable code is received via the unique identifier of the mobile device. The consumer then accesses the account information associated with the at least one utility meter via the mobile device. The unique identifier can be a media access control address. The readable code comprises a quick response (QR) code, a bar code, or an encrypted identification code and the mobile device can be a smartphone, a mobile phone, a tablet device, or a handheld communication device. Also disclosed is a method of providing access to a consumer utility account for energy management between a utility provider and a consumer comprising associating a mobile device with at least one utility meter. The mobile device comprises a unique identifier associated with the consumer and the at least one utility meter comprises a readable code. Communications from the mobile device are received after the mobile device transmits the readable code associated with the at least one utility meter. The mobile device is associated with the at least one utility meter is verified and the consumer is authorized to access account information associated with the at least one utility meter. The consumer then accesses the account information via the mobile device.
Patent NZ-602032-A (NZ)
Title: Oral b12 therapy
Inventor: CASTELLI CRISTINA
IPC: A61K31/70
Filed: 2011-02-23
Abstract: The disclosure relates to the use of one or more oral dosage forms comprising (i) N-[8-(2-hydroxybenzoyl)amino]caprylic acid or a pharmaceutically acceptable salt thereof, (ii) vitamin B12, and optionally (iii) folic acid, in the manufacture of a medicament for rapidly normalizing vitamin B12 levels in a patient having a vitamin B12 deficiency and an average vitamin B12 level below about 350 pg/mL. The medicament is for daily administration for a period of at least 15 days, wherein the medicament provides a daily total amount of N-[8-(2-hydroxybenzoyl) amino]caprylic acid or a pharmaceutically acceptable salt thereof of from about 50 to about 250 mg and a daily total amount of vitamin B12 of from about 0.5 to about 2 mg, and wherein the vitamin B12 level in the patient is normalized within 15 days. The disclosure also relates to the use of the dosage form for treating a patient with elevated methyl malonic acid (MMA) or homocysteine levels.
Patent NZ-608943-A (NZ)
Title: Processes for purification of proteins
Inventor: WANG CHEN
IPC: B01D15/36
Filed: 2011-10-11
Abstract: Disclosed is a method for purifying a protein comprising: a. providing a sample containing the protein; b. processing the sample through a capture chromatography resin to provide a first eluate comprising the protein; c. inactivating viruses in the first eluate to provide an inactivated eluate comprising the protein; d. processing the inactivated eluate through at least one depth filter to provide a filtered eluate comprising the protein, wherein the depth filtration step is followed by a capsule sterile filtration step; and e. processing the filtered eluate through at least one ion-exchange membrane to provide a second eluate comprising the protein.